Pentwater Capital Management 13F holdings, Q4 2014
Holdings as of December 31, 2014 · filings on SEC EDGAR · latest filing →
Pentwater Capital Management disclosed 87 US equity positions worth $7.4bn in its Q4 2014 13F filing. The largest position was ALLERGAN INC at 16.0% of the reported book, followed by DIRECTV and COVIDIEN PLC. Against the Q3 2014 filing, it opened 13 new positions, added to 17 and reduced 15 among the top 50 holdings.
What did Pentwater Capital Management own in Q4 2014? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2014 |
|---|---|---|---|---|---|---|---|
| 1 | ALLERGAN INC | 16.0% | $1.2bn | 5,589,600 | 53% | added | |
| 2 | DIRECTV | 12.5% | $927.0m | 10,692,400 | 1% | added | |
| 3 | COVIDIEN PLC | 10.8% | $802.1m | 7,842,400 | 98% | added | |
| 4 | TRW AUTOMOTIVE HLDGS CORP | 6.7% | $498.8m | 4,850,100 | 13% | added | |
| 5 | CAREFUSION CORP | 5.8% | $430.2m | 7,250,000 | – | new | |
| 6 | TURQUOISE HILL RES LTD | 5.6% | $412.1m | 132,946,400 | 18% | added | |
| 7 | TIME WARNER CABLE INC | 5.4% | $401.4m | 2,640,000 | 2% | added | |
| 8 | BKR BAKER HUGHES INC | Energy | 4.6% | $340.3m | 6,070,000 | – | new |
| 9 | CUBIST PHARMACEUTICALS INC | 3.5% | $260.7m | 2,590,000 | – | new | |
| 10 | SALIX PHARMACEUTICALS INC | 2.3% | $173.0m | 1,505,000 | -25% | reduced | |
| 11 | DRESSER-RAND GROUP INC | 2.2% | $165.2m | 2,020,000 | 644% | added | |
| 12 | COVANCE INC | 2.0% | $145.9m | 1,405,350 | – | new | |
| 13 | FAMILY DLR STORES INC | 1.9% | $142.6m | 1,800,000 | -2% | reduced | |
| 14 | GM GENERAL MTRS CO | Consumer Cyclical | 1.9% | $138.9m | 3,980,000 | -1% | reduced |
| 15 | ZTS ZOETIS INC | Healthcare | 1.8% | $136.8m | 3,180,000 | -25% | reduced |
| 16 | AUXILIUM PHARMACEUTICALS INC | 1.8% | $129.8m | 3,772,900 | 6760% | added | |
| 17 | INTERNATIONAL GAME TECHNOLOGY | 1.4% | $102.1m | 5,920,000 | -34% | reduced | |
| 18 | TALISMAN ENERGY INC | 1.3% | $99.2m | 12,666,800 | 252% | added | |
| 19 | DIAMOND RESORTS INTL INC | 1.2% | $87.9m | 3,150,000 | -1% | reduced | |
| 20 | PETSMART INC | 1.1% | $81.3m | 1,000,000 | 233% | added | |
| 21 | ESPERION THERAPEUTICS INC | 0.8% | $59.4m | 1,470,000 | 48% | added | |
| 22 | NPS PHARMACEUTICALS INC | 0.8% | $56.5m | 1,580,000 | 13% | added | |
| 23 | SPY SPDR S&P 500 ETF TR | 0.6% | $45.6m | 221,750 | 14% | added | |
| 24 | CHIQUITA BRANDS INTL INC | 0.6% | $42.6m | 2,945,295 | 3% | added | |
| 25 | CAESARS ENTMT CORP | 0.5% | $37.3m | 2,379,200 | 1090% | added | |
| 26 | T86 TRI POINTE HOMES INC | 0.4% | $29.9m | 1,960,000 | -6% | reduced | |
| 27 | TESLA MTRS INC | 0.4% | $29.7m | 16,000,000 | 0% | held | |
| 28 | CLOVIS ONCOLOGY INC | 0.4% | $27.7m | 494,600 | -24% | reduced | |
| 29 | EBIX INC | 0.3% | $23.8m | 1,400,000 | -26% | reduced | |
| 30 | TRULIA INC | 0.3% | $23.0m | 500,200 | – | new | |
| 31 | SPANSION INC | 0.2% | $17.8m | 520,000 | – | new | |
| 32 | KYTHERA BIOPHARMACEUTICALS I | 0.2% | $17.3m | 500,000 | -19% | reduced | |
| 33 | BOULEVARD ACQUISITION CORP | 0.2% | $17.1m | 1,775,000 | 0% | held | |
| 34 | AVANIR PHARMACEUTICALS INC | 0.2% | $16.9m | 1,000,000 | – | new | |
| 35 | ANF ABERCROMBIE & FITCH CO | Consumer Cyclical | 0.2% | $16.3m | 570,000 | -12% | reduced |
| 36 | BROOKFIELD RESIDENTIAL PPTYS | 0.2% | $15.9m | 660,402 | – | new | |
| 37 | SAPIENT CORP | 0.2% | $15.7m | 632,400 | – | new | |
| 38 | HEARTWARE INTL INC | 0.2% | $15.0m | 14,000,000 | 0% | held | |
| 39 | QSR RESTAURANT BRANDS INTL INC | Consumer Cyclical | 0.2% | $14.9m | 380,924 | – | new |
| 40 | KINDER MORGAN INC DEL | 0.2% | $13.6m | 3,200,000 | 60% | added | |
| 41 | GENTIVA HEALTH SERVICES INC | 0.2% | $11.9m | 625,556 | -58% | reduced | |
| 42 | HEARTWARE INTL INC | 0.2% | $11.7m | 160,000 | 7% | added | |
| 43 | SILVER EAGLE ACQUISITION COR | 0.1% | $10.9m | 1,114,100 | 0% | held | |
| 44 | CBS CORP NEW | 0.1% | $10.8m | 194,603 | -87% | reduced | |
| 45 | LYONDELLBASELL INDUSTRIES N | 0.1% | $9.9m | 125,000 | -48% | reduced | |
| 46 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 0.1% | $9.4m | 400,000 | -18% | reduced |
| 47 | VOLCANO CORPORATION | 0.1% | $8.9m | 500,000 | – | new | |
| 48 | CAPITOL ACQUISITION CORP II | 0.1% | $8.9m | 900,100 | 0% | held | |
| 49 | TORNIER N V | 0.1% | $8.3m | 325,785 | – | new | |
| 50 | AVOLON HLDGS LTD | 0.1% | $7.9m | 400,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.